This study demonstrated the anti-fibrotic effects of ASV in lung fibrosis, which may be due to its regulation on HMGB1 release and ECM production, suggesting an attractive pharmacological tool for the treatment of PF. The gene discussed is HMGB1; the disease is pulmonary fibrosis.